Patents by Inventor Calvin John Ross

Calvin John Ross has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SUBLINGUAL SPRAY FORMULATION COMPRISING DIHYDROARTEMESININ
    Publication number: 20190142737
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: October 18, 2018
    Publication date: May 16, 2019
    Applicant: LondonPharma Ltd.
    Inventor: CALVIN JOHN ROSS
  • SUBLINGUAL SPRAY FORMULATION COMPRISING DIHYDROARTEMESININ
    Publication number: 20170368023
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: September 6, 2017
    Publication date: December 28, 2017
    Applicant: LondonPharma Ltd.
    Inventor: Calvin John Ross
  • Sublingual Spray Formulation Comprising Dihydroartemesinin
    Publication number: 20160022629
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: July 30, 2015
    Publication date: January 28, 2016
    Applicant: LONDONPHARMA LIMITED
    Inventor: Calvin John Ross
  • Dosage dispensing canister
    Patent number: 8342370
    Abstract: A one dose at a time, non-pressurized fluid dispensing canister from which the or each dose is dispensed as a result of two surfaces (21, 22) of the canister moving towards one another under the control of the user, wherein the canister incorporates a mechanism which, once a first dose has been dispensed, automatically prevents any further dispensing movement of the surfaces (21, 22) (in the case where the canister is a one-dosage only canister) or (where the canister is a multiple-dosage-dispensing canister) allows such movement only after the two surfaces (21, 22) have first been moved in a direction or directions other than that which alone caused the first dose to be dispensed.
    Type: Grant
    Filed: August 21, 2007
    Date of Patent: January 1, 2013
    Assignee: Norwich Pharma Technologies Limited
    Inventors: Calvin John Ross, Steven John Sansom
  • Sublingual Spray Formulation Comprising Dihydroartemesinin
    Publication number: 20120157518
    Abstract: The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compositions.
    Type: Application
    Filed: April 23, 2010
    Publication date: June 21, 2012
    Applicant: LONDONPHARMA LTD.
    Inventors: Calvin John Ross, Elizabeth Anita Ross
  • DOSAGE DISPENSING CANISTER
    Publication number: 20090326442
    Abstract: A one dose at a time, non-pressurised fluid dispensing canister from which the or each dose is dispensed as a result of two surfaces (21, 22) of the canister moving towards one another under the control of the user,—characterised in that the canister incorporates a mechanism which, once a first dose has been dispensed, automatically prevents any further dispensing movement of the said surfaces (21, 22) (in the case where the canister is a one-dosage only canister) or (where the canister is a multiple-dosage-dispensing canister) allows such movement only after the two surfaces (21, 22) have first been moved in a direction or directions other than that which alone caused the first dose to be dispensed.
    Type: Application
    Filed: August 21, 2007
    Publication date: December 31, 2009
    Applicant: Norwich Pharma Technologies Limited
    Inventors: Calvin John Ross, Steven John Sansom